FNIH Trailblazer Prize for Clinician-Scientists

image: 

2018 FNIH Trailblazer Prize for Clinician-Scientist

Overview

In 2018, the Foundation for the National Institutes of Health (FNIH) presented the inagural FNIH Trailblazer Prize for Clinician-Scientists (Trailblazer Prize), which recognizes the outstanding contributions of early career clinician-scientists whose work has the potential to or has led to innovations in patient care. This $10,000 honorarium and prize celebrates the achievements of medical doctors whose research has translated basic scientific observations into new paradigm-shifting approaches for diagnosing, preventing, treating or curing disease and disability. The Trailblazer Prize is made possible by a generous donation from John I. Gallin, M.D., and Elaine Gallin, Ph.D., to the FNIH. The prize was presented at the FNIH Annual Fall Board Dinner on October 24, 2018 in Washington, D.C.

The FNIH recognizes the unique and critical role that clinician-scientists play in the evolution of medical practice. As noted in the 2014 NIH Physician-Scientist Workforce Report, these individuals play a vital role in ensuring that biomedical advances ultimately benefit patients and improve population health. Through the Trailblazer Prize, the FNIH celebrates the transformational work of clinician-scientists, whose research translates basic scientific observations into new paradigm-shifting approaches for diagnosing, preventing, treating or curing disease and disability.

2018 Recipient

Michael Fox, M.D., Ph.D., Beth Israel Deaconess Medical Center, Harvard Medical School was selected as the recipient of the inaugural FNIH Trailblazer Prize for Clinician-Scientists for developing innovative techniques to map human brain connectivity that can be translated into new treatments for neurological diseases, such as Parkinson’s disease and depression.

 

(Maria C. Freire, Ph.D., John I. Gallin, M.D., Michael Fox, M.D., Ph.D., Elaine Gallin, Ph.D., Steven M. Paul, M.D.)

 

The awardee was be selected by a jury of distinguished clinical-scientists including:

  • Steven M. Paul, M.D., (Jury Chair), Venture Partner at Third Rock Ventures
  • Barry Coller, M.D., David Rockefeller Professor of Medicine, Head of the Allen and Frances Adler Laboratory of Blood and Vascular Biology, Physician-in-Chief of the Rockefeller University Hospital, Vice President for Medical Affairs, The Rockefeller University
  • Helen H. Hobbs, M.D., Investigator, Howard Hughes Medical Institute and Professor of Internal Medicine and Molecular Genetics, University of Texas Southwestern Medical Center
  • John I. Gallin, M.D., NIH Associate Director for Clinical Research and Chief Scientific Officer of the NIH Clinical Center
  • Michael J. Welsh, M.D., Director, Pappajohn Biomedical Institute, University of Iowa

Nominators and/or candidates must not contact any member of the Trailblazer Prize jury to ask about or discuss any aspect of the prize. If this occurs, that nomination will be withdrawn from the competition.

Media

FNIH Press Release (October 25, 2018): Foundation for the NIH Bestows the Inaugural Trailblazer Prize for Clinician-Scientists to Dr. Michael Fox

FNIH Announcement (July 31, 2018): Foundation for the NIH Selects 3 Finalists for the Inaugural Trailblazer Prize for Clinician-Scientists

Contact

Please email TrailblazerPrize@fnih.org with questions.